Keapstone Therapeutics
Sheffield
About Keapstone Therapeutics
Keapstone Therapeutics provides drugs targeting, biotechnology research, amyotrophic lateral sclerosis, fatal neurodegenerative, healthcare, consulting, fasciculations, and translational neuroscience services.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $3.2M
- Funding stage: Seed
- Last round: Seed (Sep 2018)
- Website: keapstone.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Neuroscience, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/keapstone-therapeutics-183146 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.